Hwanin Benztropine Tablet 1 mg (Benztropine Mesylate)

Adult dosage

(Oral: tablets) Adults: The initial dose is benztropine mesylate 0.5-1㎎ per day orally. Thereafter, gradually increase the daily dose by 0.5㎎ every 5-6 days to the maintenance dose. Determine the maintenance dose based on improvement in symptoms and occurrence of adverse effects; do not exceed 6㎎ per day. The dose may be adjusted appropriately according to age and symptoms. (Injection) ○ Adults 1. The initial dose is benztropine mesylate 0.5-1㎎ per day by intramuscular or intravenous injection. Thereafter, gradually increase the daily dose by 0.5㎎ every 5-6 days to the maintenance dose. Determine the maintenance dose based on improvement in symptoms and occurrence of adverse effects; do not exceed 6㎎ per day. 2. In emergencies, inject 1-2㎎ of this medicine to relieve symptoms, then administer 1-2㎎ orally per dose twice daily to prevent recurrence. The injectable formulation should be administered intramuscularly or intravenously in emergencies or when oral administration is not possible. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used by patients with glaucoma, those allergic to this medication, patients with severe myasthenia gravis, and children under the age of 3. Additionally, individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also exercise caution as this medication contains lactose. This medication should be used cautiously in patients with urinary obstructive diseases such as benign prostatic hyperplasia, patients with arrhythmia or tachycardia, patients with impaired liver or kidney function, elderly patients, children over the age of 3, and individuals in hot environments. Furthermore, this medication contains a coloring agent called Yellow No. 4; patients with allergies to this component should exercise caution. Taking this medication may result in neurological side effects such as difficulty in motor control, mental confusion, hallucinations, altered consciousness, nonsensical speech, neuroticism, anxiety, depression, lethargy, and abnormal sensations in the hands and feet. Gastrointestinal side effects may include dry mouth, nausea, vomiting, and constipation. Urinary side effects such as difficulty urinating or urinary retention may rarely occur. If allergic reactions such as skin rashes occur, use should be discontinued immediately. Eye accommodation may also be impaired. When using this medication for the first time, it should be started at a low dose, with gradual dose increases while monitoring the condition. When switching from another medication to this one, the previous medication should be tapered off gradually while this medication is increased gradually. It is advisable to have regular eye examinations to check intraocular pressure during the treatment. Additionally, unlike some Parkinson's disease medications, this medication does not alleviate involuntary movements around the mouth, and may even worsen symptoms. While taking this medication, attention, concentration, and reflexes may be diminished, so driving or operating dangerous machinery should be avoided. Caution should be taken when using this medication with phenothiazine drugs, tricyclic antidepressants, MAO inhibitors, or reserpine derivatives, as it may intensify effects. Furthermore, co-administration with anticholinergic medications may cause severe constipation, abdominal distension, or intestinal obstruction; if such symptoms occur, the medication should be discontinued immediately. The safety of this medication during pregnancy or breastfeeding is not well established, so it is advised that women who are pregnant, possibly pregnant, or breastfeeding refrain from using this medication.

• Ataxia
• delirium
• hallucinations
• altered consciousness
• delirium
• nervous irritability
• agitation
• anxiety
• depression
• lethargy

This medication may be sensitive to light, so it should be stored in a light-proof and tightly sealed container. This helps to keep its components unchanged and maintain efficacy for a longer period.

Appearance

Yellow round tablet

Package unit

500 tablets/bottle